1. Medicine
  2. Microbiology and Infectious Disease

Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis

  1. Tyler Wagner
  2. FNU Shweta
  3. Karthik Murugadoss
  4. Samir Awasthi
  5. AJ Venkatakrishnan
  6. Sairam Bade
  7. Arjun Puranik
  8. Martin Kang
  9. Brian W Pickering
  10. John C O'Horo
  11. Philippe R Bauer
  12. Raymund R Razonable
  13. Paschalis Vergidis
  14. Zelalem Temesgen
  15. Stacey Rizza
  16. Maryam Mahmood
  17. Walter R Wilson
  18. Douglas Challener
  19. Praveen Anand
  20. Matt Liebers
  21. Zainab Doctor
  22. Eli Silvert
  23. Hugo Solomon
  24. Akash Anand
  25. Rakesh Barve
  26. Gregory Gores
  27. Amy W Williams
  28. William G Morice
  29. John Halamka
  30. Andrew Badley, MD  Is a corresponding author
  31. Venky Soundararajan  Is a corresponding author
  1. nference, United States
  2. Mayo Clinic, United States
  3. nference Labs, India
  4. nference, India
  5. Mayo Clinic Laboratories, United States
https://doi.org/10.7554/eLife.58227
Share this article
Cite this article
  1. Tyler Wagner
  2. FNU Shweta
  3. Karthik Murugadoss
  4. Samir Awasthi
  5. AJ Venkatakrishnan
  6. Sairam Bade
  7. Arjun Puranik
  8. Martin Kang
  9. Brian W Pickering
  10. John C O'Horo
  11. Philippe R Bauer
  12. Raymund R Razonable
  13. Paschalis Vergidis
  14. Zelalem Temesgen
  15. Stacey Rizza
  16. Maryam Mahmood
  17. Walter R Wilson
  18. Douglas Challener
  19. Praveen Anand
  20. Matt Liebers
  21. Zainab Doctor
  22. Eli Silvert
  23. Hugo Solomon
  24. Akash Anand
  25. Rakesh Barve
  26. Gregory Gores
  27. Amy W Williams
  28. William G Morice
  29. John Halamka
  30. Andrew Badley, MD
  31. Venky Soundararajan
(2020)
Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis
eLife 9:e58227.
https://doi.org/10.7554/eLife.58227
  2. Download BibTeX
  3. Download .RIS

Abstract

Understanding temporal dynamics of COVID-19 patient symptoms could provide fine-grained resolution to guide clinical decision-making. Here, we use deep neural networks over an institution-wide platform for the augmented curation of clinical notes from 77,167 patients subjected to COVID-19 PCR testing. By contrasting Electronic Health Record (EHR)-derived symptoms of COVID-19-positive (COVIDpos; n=2,317) versus COVID-19-negative (COVIDneg; n=74,850) patients for the week preceding the PCR testing date, we identify anosmia/dysgeusia (27.1-fold), fever/chills (2.6-fold), respiratory difficulty (2.2-fold), cough (2.2-fold), myalgia/arthralgia (2-fold), and diarrhea (1.4-fold) as significantly amplified in COVIDpos over COVIDneg patients. The combination of cough and fever/chills has 4.2-fold amplification in COVIDpos patients during the week prior to PCR testing, and along with anosmia/dysgeusia, constitutes the earliest EHR-derived signature of COVID-19. This study introduces an Augmented Intelligence platform for the real-time synthesis of institutional biomedical knowledge. The platform holds tremendous potential for scaling up curation throughput, thus enabling EHR-powered early disease diagnosis.

Data availability

The EHR dataset where augmented curation was conducted from the Mayo Clinic records was accessed under IRB 20-003278, "Study of COVID-19 patient characteristics with augmented curation of Electronic Health Records (EHR) to inform strategic and operational decisions". The EHR data cannot be shared or released due to HIPAA regulations. Contact corresponding authors for additional details regarding the IRB, and please refer to the Mayo Clinic IRB website for further details on our commitment to patient privacy (https://www.mayo.edu/research/institutional-review-board/overview). The summary statistics derived from the EHRs are enclosed within the manuscript.

Article and author information

Author details

  1. Tyler Wagner

    R and D, nference, Cambridge, United States
    Competing interests
    Tyler Wagner, is an employee of nference and has financial interests in the company..

  2. FNU Shweta

    Department of Medicine, Mayo Clinic, Rochester, United States
    Competing interests
    FNU Shweta, has a Financial Conflict of Interest in technology used in the research and with Mayo Clinic may stand to gain financially from the successful outcome of the research. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic Conflict of Interest policies..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6634-6272

  3. Karthik Murugadoss

    Data Sciences, nference, Cambridge, United States
    Competing interests
    Karthik Murugadoss, is an employee of nference and has financial interests in the company..

  4. Samir Awasthi

    R and D, nference, Cambridge, United States
    Competing interests
    Samir Awasthi, is an employee of nference and has financial interests in the company..

  5. AJ Venkatakrishnan

    R and D, nference, Cambridge, United States
    Competing interests
    AJ Venkatakrishnan, is an employee of nference and has financial interests in the company..

  6. Sairam Bade

    Data Sciences, nference Labs, Bangalore, India
    Competing interests
    Sairam Bade, is an employee of nference and has financial interests in the company..

  7. Arjun Puranik

    Data Science, nference, San Francisco, United States
    Competing interests
    Arjun Puranik, is an employee of nference and has financial interests in the company..

  8. Martin Kang

    R and D, nference, Cambridge, United States
    Competing interests
    Martin Kang, is an employee of nference and has financial interests in the company..

  9. Brian W Pickering

    Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, United States
    Competing interests
    Brian W Pickering, has a Financial Conflict of Interest in technology used in the research and with Mayo Clinic may stand to gain financially from the successful outcome of the research. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic Conflict of Interest policies..

  10. John C O'Horo

    Division of Infectious Diseases, Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, United States
    Competing interests
    John C O'Horo, has a Financial Conflict of Interest in technology used in the research and with Mayo Clinic may stand to gain financially from the successful outcome of the research. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic Conflict of Interest policies..

  11. Philippe R Bauer

    Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, United States
    Competing interests
    Philippe R Bauer, has a Financial Conflict of Interest in technology used in the research and with Mayo Clinic may stand to gain financially from the successful outcome of the research. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic Conflict of Interest policies..

  12. Raymund R Razonable

    Division of Infectious Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, United States
    Competing interests
    Raymund R Razonable, has a Financial Conflict of Interest in technology used in the research and with Mayo Clinic may stand to gain financially from the successful outcome of the research. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic Conflict of Interest policies..

  13. Paschalis Vergidis

    Infectious Diseases, Mayo Clinic, Rochester, United States
    Competing interests
    Paschalis Vergidis, has a Financial Conflict of Interest in technology used in the research and with Mayo Clinic may stand to gain financially from the successful outcome of the research. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic Conflict of Interest policies..

  14. Zelalem Temesgen

    Infectious Diseases, Mayo Clinic, Rochester, United States
    Competing interests
    Zelalem Temesgen, has a Financial Conflict of Interest in technology used in the research and with Mayo Clinic may stand to gain financially from the successful outcome of the research. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic Conflict of Interest policies..

  15. Stacey Rizza

    Division of Infectious Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, United States
    Competing interests
    Stacey Rizza, has a Financial Conflict of Interest in technology used in the research and with Mayo Clinic may stand to gain financially from the successful outcome of the research. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic Conflict of Interest policies..

  16. Maryam Mahmood

    Infectious Diseases, Mayo Clinic, Rochester, United States
    Competing interests
    Maryam Mahmood, has a Financial Conflict of Interest in technology used in the research and with Mayo Clinic may stand to gain financially from the successful outcome of the research. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic Conflict of Interest policies..

  17. Walter R Wilson

    Department of Orthopedic Surgery, Division of Infectious Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, United States
    Competing interests
    Walter R Wilson, has a Financial Conflict of Interest in technology used in the research and with Mayo Clinic may stand to gain financially from the successful outcome of the research. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic Conflict of Interest policies..

  18. Douglas Challener

    Infectious Diseases, Mayo Clinic, Rochester, United States
    Competing interests
    Douglas Challener, has a Financial Conflict of Interest in technology used in the research and with Mayo Clinic may stand to gain financially from the successful outcome of the research. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic Conflict of Interest policies..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6964-9639

  19. Praveen Anand

    R and D, nference, Bangalore, India
    Competing interests
    Praveen Anand, is an employee of nference and has financial interests in the company..

  20. Matt Liebers

    R and D, nference, Cambridge, United States
    Competing interests
    Matt Liebers, is an employee of nference and has financial interests in the company..

  21. Zainab Doctor

    R and D, nference, Cambridge, United States
    Competing interests
    Zainab Doctor, is an employee of nference and has financial interests in the company..

  22. Eli Silvert

    Data Sciences, nference, Cambridge, United States
    Competing interests
    Eli Silvert, is an employee of nference and has financial interests in the company..

  23. Hugo Solomon

    R&D, nference, Cambridge, United States
    Competing interests
    Hugo Solomon, is an employee of nference and has financial interests in the company..

  24. Akash Anand

    Data Science, nference, Bangalore, India
    Competing interests
    Akash Anand, is an employee of nference and has financial interests in the company..

  25. Rakesh Barve

    Data Sciences, nference, Bangalore, India
    Competing interests
    Rakesh Barve, is an employee of nference and has financial interests in the company..

  26. Gregory Gores

    Department of Orthopedic Surgery, Division of Infectious Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, United States
    Competing interests
    Gregory Gores, has a Financial Conflict of Interest in technology used in the research and with Mayo Clinic may stand to gain financially from the successful outcome of the research. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic Conflict of Interest policies..

  27. Amy W Williams

    Division of Nephrology & Internal Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, United States
    Competing interests
    Amy W Williams, has a Financial Conflict of Interest in technology used in the research and with Mayo Clinic may stand to gain financially from the successful outcome of the research. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic Conflict of Interest policies..

  28. William G Morice

    Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic Laboratories, Rochester, United States
    Competing interests
    William G Morice, has a Financial Conflict of Interest in technology used in the research and with Mayo Clinic may stand to gain financially from the successful outcome of the research. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic Conflict of Interest policies..

  29. John Halamka

    Mayo Clinic Platform, Mayo Clinic, Rochester, United States
    Competing interests
    John Halamka, has a Financial Conflict of Interest in technology used in the research and with Mayo Clinic may stand to gain financially from the successful outcome of the research. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic Conflict of Interest policies..

  30. Andrew Badley, MD

    Mayo Clinic Platform, Mayo Clinic, Rochester, United States
    For correspondence
    Badley.Andrew@mayo.edu
    Competing interests
    Andrew Badley, MD, has a Financial Conflict of Interest in technology used in the research and with Mayo Clinic may stand to gain financially from the successful outcome of the research. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic Conflict of Interest policies..

  31. Venky Soundararajan

    R&D, nference, Cambridge, United States
    For correspondence
    venky@nference.net
    Competing interests
    Venky Soundararajan, is an employee of nference and has financial interests in the company..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7434-9211

Funding

National Institute of Allergy and Infectious Diseases (AI 110173)

  • Andrew Badley, MD

National Institute of Allergy and Infectious Diseases (AI120698)

  • Andrew Badley, MD

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: This research was conducted under IRB 20-003278, "Study of COVID-19 patient characteristics with augmented curation of Electronic Health Records (EHR) to inform strategic and operational decisions". All analysis of EHRs was performed in the privacy-preserving environment secured and controlled by the Mayo Clinic. nference and the Mayo Clinic subscribe to the basic ethical principles underlying the conduct of research involving human subjects as set forth in the Belmont Report and strictly ensures compliance with the Common Rule in the Code of Federal Regulations (45 CFR 46) on Protection of Human Subjects. Please refer to the Mayo Clinic IRB website for further information - https://www.mayo.edu/research/institutional-review-board/overview

Copyright

© 2020, Wagner et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 10,332
    views
  • 435
    downloads
  • 85
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Tyler Wagner
  2. FNU Shweta
  3. Karthik Murugadoss
  4. Samir Awasthi
  5. AJ Venkatakrishnan
  6. Sairam Bade
  7. Arjun Puranik
  8. Martin Kang
  9. Brian W Pickering
  10. John C O'Horo
  11. Philippe R Bauer
  12. Raymund R Razonable
  13. Paschalis Vergidis
  14. Zelalem Temesgen
  15. Stacey Rizza
  16. Maryam Mahmood
  17. Walter R Wilson
  18. Douglas Challener
  19. Praveen Anand
  20. Matt Liebers
  21. Zainab Doctor
  22. Eli Silvert
  23. Hugo Solomon
  24. Akash Anand
  25. Rakesh Barve
  26. Gregory Gores
  27. Amy W Williams
  28. William G Morice
  29. John Halamka
  30. Andrew Badley, MD
  31. Venky Soundararajan
(2020)
Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis
eLife 9:e58227.
https://doi.org/10.7554/eLife.58227

Share this article

https://doi.org/10.7554/eLife.58227

Categories and tags

Research organism

Further reading

    1. Medicine

    Inference from longitudinal laboratory tests characterizes temporal evolution of COVID-19-associated coagulopathy (CAC)

    Colin Pawlowski, Tyler Wagner ... Venky Soundararajan
    Research Article Updated

    Temporal inference from laboratory testing results and triangulation with clinical outcomes extracted from unstructured electronic health record (EHR) provider notes is integral to advancing precision medicine. Here, we studied 246 SARS-CoV-2 PCR-positive (COVIDpos) patients and propensity-matched 2460 SARS-CoV-2 PCR-negative (COVIDneg) patients subjected to around 700,000 lab tests cumulatively across 194 assays. Compared to COVIDneg patients at the time of diagnostic testing, COVIDpos patients tended to have higher plasma fibrinogen levels and lower platelet counts. However, as the infection evolves, COVIDpos patients distinctively show declining fibrinogen, increasing platelet counts, and lower white blood cell counts. Augmented curation of EHRs suggests that only a minority of COVIDpos patients develop thromboembolism, and rarely, disseminated intravascular coagulopathy (DIC), with patients generally not displaying platelet reductions typical of consumptive coagulopathies. These temporal trends provide fine-grained resolution into COVID-19 associated coagulopathy (CAC) and set the stage for personalizing thromboprophylaxis.

    1. Epidemiology and Global Health
    2. Medicine
    3. Microbiology and Infectious Disease

    COVID-19: A Collection of Articles

    Edited by Diane M Harper et al.
    Collection

    eLife has published the following articles on SARS-CoV-2 and COVID-19.

    1. Medicine
    2. Microbiology and Infectious Disease
    3. Epidemiology and Global Health
    4. Immunology and Inflammation

    Infectious Diseases: A Collection of Translational and Clinical Research Articles

    Edited by Jos WM van der Meer et al.
    Collection

    eLife has published articles on a wide range of infectious diseases, including COVID-19, influenza, tuberculosis, HIV/AIDS, malaria and typhoid fever.